Press Releases CVRx, Inc.

Equities

CVRX

US1266381052

Delayed Nasdaq Other stock markets 03:47:04 2024-06-11 pm EDT			5-day change	1st Jan Change
9.53 ^USD	+4.38%		+46.84%	-69.69%

May. 16	CVRx, Inc. Announces Executive Appointments	CI
May. 02	North American Morning Briefing : Stock Futures -3-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX	Jun. 07	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX	May. 30	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX	May. 23	PR
CVRx to Present at the William Blair 44th Annual Growth Stock Conference	May. 22	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX	May. 16	PR
CVRx Announces Key Senior Leadership Team Hires	May. 16	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. - CVRX	May. 06	PR
CVRx: Q1 Earnings Snapshot	Apr. 30	AQ
CVRx Reports First Quarter 2024 Financial and Operating Results	Apr. 30	AQ
CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024	Apr. 16	AQ
CVRx announces availability of additional data supporting long-term benefits of Barostim	Apr. 15	AQ
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer	Jan. 31	AQ
CVRx: Q4 Earnings Snapshot	Jan. 25	AQ
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results	Jan. 25	AQ
CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024	Jan. 11	AQ
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans	Jan. 08	AQ
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Dec. 27	AQ
CVRx receives FDA approval for expanded labeling of BarostimU.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF data	Dec. 27	AQ
CVRx receives FDA approval for expanded labeling of Barostim	Dec. 26	AQ
CVRx : New Financial Obligation - Form 8-K	Dec. 15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases CVRx, Inc.

Equities

CVRX

US1266381052

Press Releases

Filters